Ask the MD: Stem Cells and Parkinson’s Disease

Ask the MD: Stem Cells and Parkinson’s Disease

Publication date: Aug 09, 2019

People with Parkinson’s and their families often ask about stem cells – their potential to treat disease, the state of ongoing research, and the safety of unproven stem cell therapies offered outside of clinical studies. Rachel Dolhun, MD, movement disorder specialist and vice president of medical communications at The Michael J. Fox Foundation, discusses the facts about stem cells and Parkinson’s.

The “Ask the MD” series is intended as an educational resource for people with Parkinson’s and their loved ones. Please consult with your personal healthcare provider to address individual medical questions.

The Michael J. Fox Foundation for Parkinson’s Research is dedicated to finding a cure for Parkinson’s disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson’s today. https://www.michaeljfox.org

We gratefully acknowledge the Steering Committee members of our Patient Disease Education Consortium in conjunction with The Albert B. Glickman Parkinson’s Disease Education Program and Charles B. Moss Jr. and family, whose sponsorship allows us to create and distribute materials, while preserving our track record of efficiency in stewarding donor-raised contributions for maximum impact on Parkinson’s drug development. Sponsorship support does not influence MJFF’s content perspective or panelist selection.

Note: Tap cc in the lower right corner of the player to enable auto-generated captions for the video.

Concepts Keywords
Air Stem cells
Blood Life sciences
Brain Branches of biology
Clinical Trials Disorder
Dopamine Treat disease
Drug Development Biotechnology
Embryonic Stem Cells Parkinson’s disease
Fat Embryonic stem cell
Fat Cells Stem-cell therapy
Fax Adult stem cell
Genetic Stem cells
Healthcare Drug development
Memory
Movement Disorder
Parkinson
Sleep
Stay Alive
Stem Cell
Stem Cells
Stiffness
Thes
Tremor

Semantics

Type Source Name
gene UNIPROT DBF4
gene UNIPROT ARSK
disease MESH movement disorder
disease MESH development
drug DRUGBANK Nonoxynol-9
gene UNIPROT IMPACT
gene UNIPROT NXF1
gene UNIPROT SEC14L2
gene UNIPROT USO1
gene UNIPROT FLNB

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *